SENORES PHARMACEUTICALS L (SENORES) — Tangible Net Worth Ratio
SENORES PHARMACEUTICALS L (SENORES) has a Tangible Net Worth Ratio of 64.9% as of March 2026. This metric is calculated by deducting intangible assets (Rs3.39 Billion) from net assets (Rs9.65 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore SENORES PHARMACEUTICALS L annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
SENORES PHARMACEUTICALS L Tangible Net Worth Ratio (2022–2026)
This chart shows how SENORES PHARMACEUTICALS L's Tangible Net Worth Ratio has changed across 5 annual periods from 2022 to 2026. As of March 2026, the ratio stands at 64.9%, reflecting net assets of Rs9.65 Billion with intangible assets of Rs3.39 Billion INR.
Annual Tangible Net Worth Ratio for SENORES PHARMACEUTICALS L (2022–2026)
The table below presents the year-by-year Tangible Net Worth Ratio for SENORES PHARMACEUTICALS L from 2022 to 2026, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see SENORES PHARMACEUTICALS L market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (INR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 64.9% | Rs9.65 Billion | Rs3.39 Billion | Rs16.04 Billion | ▲ +1887.7 pp |
| 2025 | -1822.9% | Rs94.96 Million | Rs1.83 Billion | Rs145.66 Million | ▼ -1873.2 pp |
| 2024 | 50.3% | Rs2.32 Billion | Rs1.15 Billion | Rs6.22 Billion | ▲ +52.4 pp |
| 2023 | -2.1% | Rs454.99 Million | Rs464.43 Million | Rs1.31 Billion | ▼ -77.9 pp |
| 2022 | 75.8% | Rs365.90 Million | Rs88.42 Million | Rs591.52 Million | — |